IAVI Report Vol. 2, no. 2
International Call for Action n May 18,1997, United States President Bill Clinton asked. that we "commit ourselves to developing an AIDS vaccine within the next decade." AIDS has already taken the lives of millions of men, women and children. More than 29 million individuals have been infected with. HIV. Each day, approximately 10,000 new infections occur, almost 95 percent of these in the developing world. The investment of substantial government and private sector funds, over a sustained period of time, enabled researchers to make extraordinary progress in developing new HIV therapeutics. Tragically, these advances are far beyond the reach of most HIVinfected individuals in the world. An effort of similar magnitude is needed to develop HIV vaccines, without which AIDS will continue its relentless march of destruction. President Clinton stated that at the Summit of the Industrialized Nations in Denver, he will seek to "enlist other nations to join in a worldwide effort to find a vaccine to stop one of the world's greatest killers." We, the undersigned, believe that HIV 'disease is a global disease and requires a global response. No single country or company has the resources to go it alone. Therefore, we call upon the industrialized nations of the world to support a global effort to develop safe, effective, preventive HIV vaccines for use throughout the world by 2007. We call upon the nations participating in the on -VIVaccine De lopnent Denver Summit to agree on a specific plan' to mee t goal:. We also. call upon the large industrialized nations to.devote new resources.to this-vaccine development effortincluding assuring that vaccines are produced for developing countries, creating incentives for maximum participation of the pharmaceutical/vaccine industry, and agreement on specific mechanisms to ensure mutual cooperation and coordination of the effort. The excruciating burden of this disease demands that funds not be diverted fromresearch for HV therapeutics or prevention. The creation of iew financiig mechanisms, such as an AIDS Vaccine Development Fund and AIDS Vaccine Purchase Fund, should be considered, Finally, we call upon the large',industrialized nations to expand this effort to other international forums, including the G-77 nations. The industrialized nations must begin working with each other and less developed countries, private industry, international agencies, and. non-governmental organizations to lay the groundwork for maximizing the research effort and securing broad international access to any HIV vaccines that are developed. I All countries around the world will gain by this effort and each has a unique contribution to make, such as providing funding, scientists, testing sites, and vaccine production. A global effort of this magnitude would demonstrate how the world can come together in an era of globalization for the good of all humankind - a noble goal for the next century. ENDORSING ORGANIZATIONS Accion Ciudadana Contra el SIDA (ACCS), Venezuela;Agency for Cooperation in International Health, Japan;AIDSAction Baltimore, Inc., US.; AIDSAction Council, US.;AIDS Coordination Group, Netherlands;AIDS Education Global Information System (AEGIS), US.;AIDS Helpline-NI, United Kingdom;AIDS Treatment News, US.;AIDS Vaccine Advocacy Coalition (AVAC), US.;Albert B. Sabin Vaccine Foundation, US.;All India Institute of Medical Sciences, India;Association-against HIVAIDS, Russia;Association de Recherche, de Communication.et dAction pour le Traitement du SIDA (ARCATSIDA), FranceAssociazione Nazionale per la Lotta contro lAIDS (AATLAIDS), Italy; British Medical Association, United Kingdom;British MedicalAssociation Foundation forAUDS, United Kingdom; Center forAIDS Prevention Studies.(CAPS), US;Centerfor Vaccine Development, Mahidol University at Salaya, Thailand; Center of Research andAdvanced Treatment in AIDS and HIV(CMAID), Mexico; Corporacion Chilena de Prevencion del Sida (CChPS), Chile;DeutscheAIDSStiflung, Germany;EuroCASO Secretariat, Netherlands; European Public Policy Network on AIDS (EPPNA), United Kingdom; Family Health Trust, Zambia; Fondation Marcel Mdrieux, France; Fundapao Oswaldo Cruz (FIOCRUZ), Brazil; Gay Men's Health Crisis (GMHC), US; Global AIDSAction Network (GAAN), US.; Global Network of People Living with HIVAIDS (GNP+), flS.;HIV Community Coalition ofMetropolitan Washington, DC, US.;HIV/AIDS STDActivities in Bangladesh (IASAB), Bangladesh; Holistic Health Cente, US; Immigrants Fighting AIDS, US.; International AIDS Vaccine Initiative, US.; International Center for Research on Women, US.; International Christian AIDS Network (ICAA9, United Kingdom; International Community of Women Living withAIDS (ICM, United Kingdom; International Council ofAIDS Service Organizations (ICASO), Canada; International Council offewish Women, United Kingdom; International Lesbian and Gay Association, Belgium;International Union against the Venereal Disease and the Treponematoses,Australia;Jonas Salk Foundation, US.;Kenya NationalAIDS Control Programme, Kenya; Latino Comission on AIDS, US.; Liga Colombiana de Lucha contra el Sida, Colombia; London Lighthouse, United Kingdom; Marathon of Mothers, US.;Mother's Voices, US;Mothers Organizing Mothers (MOMS), US.;National AIDS Fund, US.; National AIDS Trust, United Kingdom; NationalAssociation of People withAIDS (NAPWA), US;National Lesbian and Gay Health Association (NLGlA), US.;Nederlandse Vereniging tot Integratie van Homoseksualiteit COC, Netherlands; Network of Self-Help HIV andAIDS Groups, United Kingdom; People with AIDS Health Group, US.; ProjectInform, US.; San Francisco AIDS Foundation, US; Scottish Voluntary HIV and AIDS Forum, United Kingdom; Southern Africa AIDS Information Dissemination Service (SAfAIDS), Zimbabwe; St. Paul's Trust Initiative for AIDSfree India, India; The Terrence Higgins Trust, United Kingdom;Title II Community AIDS National Network, US.;TreatmentAction Group, US.; UCSFAIDS Research Institute, US.; Uganda Cancer Institute, Uganda; UK Coalition of People Living with PIV & AIDS, United Kingdom; Until There's A Cure Foundation, US.; Vaccine Advocates, US IAVI is continuing to obtain organizational endorsements for this CallforAction. To sign on, call +1-212-377-2700, fax: +1-212-377-2727 or e-maik [email protected]. IAVIReport DviiGod Eor amvett,'!,A nxg-hreserve Toobain i "fjure ues c "1s Fioo'r, New ork<,NY- I10,USA; 'or b
About this Item
- Title
- IAVI Report Vol. 2, no. 2
- Author
- International AIDS Vaccine Initiative
- Canvas
- Page 12
- Publication
- International AIDS Vaccine Initiative
- 1997
- Subject terms
- newsletters
- Series/Folder Title
- Disease Management > AIDS Vaccines > Research > Vaccines, Attenuated
- Item type:
- newsletters
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0356.010
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0356.010/12
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0356.010
Cite this Item
- Full citation
-
"IAVI Report Vol. 2, no. 2." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0356.010. University of Michigan Library Digital Collections. Accessed June 10, 2025.